Harrow (HROW) Net Margin Growth (3y) (2016 - 2026)
Harrow (HROW) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | -1,181.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,181.00 |
| Mar 31, 2026 | -3,699.00 |
| Dec 31, 2025 | 648.00 |
| Sep 30, 2025 | 2,975.00 |
| Jun 30, 2025 | 3,459.00 |
| Mar 31, 2025 | -2,615.00 |
| Dec 31, 2024 | 4,689.00 |
| Sep 30, 2024 | 3,594.00 |
| Jun 30, 2024 | 304.00 |
| Mar 31, 2024 | -4,063.00 |
| Dec 31, 2023 | -3,304.00 |
| Sep 30, 2023 | -7,281.00 |
| Jun 30, 2023 | -969.00 |
| Mar 31, 2023 | 8,391.00 |
| Dec 31, 2022 | -1,544.00 |
| Sep 30, 2022 | 6,286.00 |
| Jun 30, 2022 | -885.00 |
| Mar 31, 2022 | -10,323.00 |
| Dec 31, 2021 | -19,600.00 |
| Sep 30, 2021 | -2,110.00 |